METHOD FOR REDUCING BODY WEIGHT AND/OR BODY FAT, OR PREVENTING AN INCREASE IN BODY WEIGHT AND/OR BODY FAT, OR FACILITATING A REDUCTION IN BODY WEIGHT ND/OR BODY FAT, IN A PATIENT DIAGNOSED OF BEING OVERWEIGHT OR OBESE, USING EMPAGLIFLOZIN AND ANTIOBESITY DRUG

摘要

The application describes a method for reducing body weight and/or body fat, or preventing an increase in body weight and/or body fat, or facilitating a reduction in body weight and/or body fat, in a patient diagnosed of being overweight or obese, characterized in that empagliflozin in the amount of 1 to 50 mg per day and one or more antiobesity drugs selected from the group consisting of sibutramine, orlistat and cetilistat are administered to the patient.